Clinical Trial Update: Pilot Study to Evaluate SYL1001 Safety and Effect in Patients With Ocular Pain [Phase 1, Phase 2]

View source ↗

Summary

A pilot Phase 1/2 study evaluated the safety and preliminary efficacy of SYL1001 in patients with ocular pain and dry eye syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome
• Ocular Pain

Drugs mentioned

• SYL1001

Snippet

Sponsor: Sylentis, S.A. | Conditions: Ocular Pain, Dry Eye Syndrome | Phase 1, Phase 2 | Status: COMPLETED